Scientists at the University of East Anglia, UK, in collaboration with the University Pompeu Fabra in Barcelona had last year discovered how the main psychoactive ingredient in cannabis, known as THC, reduces tumour growth in cancer patients.
Their latest findings, published in the journal PLOS Biology, show how the cognitive effects of THC are triggered by a pathway which is separate from some of its other effects.
The research was carried out in mice, but it is hoped that the breakthrough will pave the way for safe cannabis-based therapies that do not cause alterations in mood, perception or memory.
"THC, the major active component of marijuana, has broad medical use - including for pain relief, nausea and anxiety," said Dr Peter McCormick, from UEA's school of Pharmacy.
"Our previous research has also found that it could reduce tumour size in cancer patients. However it is also known to induce numerous undesirable side effects such as memory impairment, anxiety and dependence," he said.
"THC acts through a family of cell receptors called cannabinoid receptors. Our previous research revealed which of these receptors are responsible for the anti-tumour effects of THC.
"This new research demonstrates how some of the drug's beneficial effects can be separated from its unwanted side effects," said McCormick.
The research team carried out behavioural studies in mice and investigated how pathways in their brains operate under THC.
They found that the absence of a particular serotonin receptor (5HT2AR) reduced some of the effects of THC - such as its amnesic effect, based on a standard memory test. But treatment to reduce 5HT2AR did not change other effects of THC, including pain relief.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
